PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

KENG-HSUEH LAN2018-09-102018-09-102004http://www.scopus.com/inward/record.url?eid=2-s2.0-5144226211&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/306633[SDGs]SDG1PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsjournal article10.1016/j.ccr.2004.06.022